Tables
- TABLE 1
Change in asthma control parameters between baseline, follow-up 1 and follow-up 2
Baseline (n=35) Follow-up 1 (n=35) Follow-up 2 (n=35) p-value: comparison baseline versus follow-up 1 p-value: comparison follow-up 1 versus follow-up 2 FEV1, % pred 82.2±21.8 92.5±16.1 95.8±16.2 <0.001 0.087 BDR, % 20.3±22.8# 8.7±10.4# 7.2±9.3¶ <0.001 0.445 FeNO, ppb 55 (26–87)¶ 21 (13–61)¶ 22.5 (11–40)+ 0.002 0.724 mPAQLQ 3.5 (3–4.7) 5.5 (4.3–6.4) 5.9 (4.3–6.8)¶ 0.001 0.006 Exacerbations, n 2 (0–8) 1 (0–4)# 0 (0–4) 0.033 0.001 Adherence Not assessed 78 (54–92) 83 (56–93) 0.302 ACT 12.6±6.1# 16.2±6.1# 19.1±5.8¶ 0.001 0.005 Data are presented as mean±sd or median (interquartile range), unless otherwise stated. According to the data distribution, Wilcoxon signed rank or paired t-test were used. FEV1: forced expiratory volume in 1 s; BDR: bronchodilator reversibility; FeNO: exhaled nitric oxide fraction; mPAQLQ: median paediatric quality of life questionnaire score; ACT: Asthma Control Test. #: missing data for one child; ¶: missing data for two children; +: missing data for five children.